ArticleFrontiers in pediatrics2026
Admission-time immunologic patterns in hospitalized children with
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Targeted next-generation sequencing (tNGS) provides a semi-quantitative signal of Methods: We conducted a retrospective cohort study of hospitalized children with tNGS-confirmed MPP from January to December 2024. Co-detection profiles and associated clinical characteristics were summarized in the full cohort. Formal load-titer phenotyping was restricted to children with MP-only pneumonia to reduce co-detection-related heterogeneity. In this subgroup, two-dimensional kernel density estimation (2D-KDE) was applied to log₁₀-transformed normalized MP reads and log₂(titer + 1)-transformed antibody titers. Onset-to-admission intervals were also summarized across antibody titer categories. Results: Among 402 children, MP-only, MP + viral co-detection, and MP + bacterial co-detection accounted for 39.3%, 30.1%, and 30.6% of children, respectively. MP + viral co-detection was associated with younger age, longer cough duration, higher white blood cell (WBC) and platelet counts, lower C-reactive protein (CRP), higher antibody titers, and slightly greater resource use, whereas MP + bacterial co-detection generally resembled MP-only. Antibody titers showed a timing-related gradient: children with the first positive titer level of 1:40 were typically admitted around day 6 after illness onset, whereas very high titers corresponded to longer onset-to-admission intervals. Among 158 children with MP-only pneumonia, 2D-KDE suggested three admission-time molecular-serologic patterns: P1 high-load/seronegative, P2 high-load/high-titer, and P3 lower-load/high-titer, accounting for 29.7%, 45.6%, and 24.7% of children, respectively. Across P1-P3, onset-to-admission interval and fever duration increased, the neutrophil-to-lymphocyte (N/L) ratio rose, and platelet counts peaked in P2 before partially declining in P3. Conclusions: Admission-time molecular load-antibody titer phenotyping in children with MP-only hospitalized MPP suggested three immunologic patterns. The high-load/high-titer pattern indicates that persistent MP molecular signal and established humoral response may coexist at hospitalization. This joint framework may help clinicians contextualize MP tNGS signals in relation to host immune status and illness timing, rather than relying on molecular load or antibody titer alone.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.